1. Home
  2. FFIC vs EOLS Comparison

FFIC vs EOLS Comparison

Compare FFIC & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flushing Financial Corporation

FFIC

Flushing Financial Corporation

HOLD

Current Price

$16.97

Market Cap

552.3M

Sector

Finance

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$6.81

Market Cap

444.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FFIC
EOLS
Founded
1929
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
552.3M
444.0M
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
FFIC
EOLS
Price
$16.97
$6.81
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$20.80
AVG Volume (30 Days)
255.7K
1.8M
Earning Date
10-29-2025
11-05-2025
Dividend Yield
5.20%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$143,853,000.00
$285,823,000.00
Revenue This Year
$113.60
$14.36
Revenue Next Year
$7.42
$23.27
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.10
52 Week Low
$10.65
$5.71
52 Week High
$17.94
$17.12

Technical Indicators

Market Signals
Indicator
FFIC
EOLS
Relative Strength Index (RSI) 74.86 49.55
Support Level $16.11 $6.36
Resistance Level $16.63 $7.15
Average True Range (ATR) 0.46 0.31
MACD 0.10 -0.03
Stochastic Oscillator 95.77 36.69

Price Performance

Historical Comparison
FFIC
EOLS

About FFIC Flushing Financial Corporation

Flushing Financial Corp operates as a bank holding company, which is engaged in the provision of banking and financial services. It provides Personal, Business, lending, Government banking, and Card services. Its principal business is attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, in originations and purchases of multi-family residential properties, commercial business loans, commercial real estate mortgage loans, construction loans, small business administration loans, and other small business loans.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: